Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms
- 1 February 1997
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 41 (3) , 377-380
- https://doi.org/10.1016/s0006-3223(96)00406-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cytochrome P450 EnzymesJournal of Clinical Psychopharmacology, 1996
- Relationship of In Vitro Data on Drug Metabolism to In Vivo Pharmacokinetics and Drug InteractionsJournal of Clinical Psychopharmacology, 1996
- Coadministration of Nefazodone and BenzodiazepinesJournal of Clinical Psychopharmacology, 1995
- The Emerging Role of Cytochrome P450 3A in PsychopharmacologyJournal of Clinical Psychopharmacology, 1995
- Coadministration of Nefazodone and BenzodiazepinesJournal of Clinical Psychopharmacology, 1995
- Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and DiazepamThe Journal of Clinical Pharmacology, 1995
- Inhibition of Alprazolam and Desipramine Hydroxylation In Vitro by Paroxetine and FluvoxamineJournal of Clinical Psychopharmacology, 1995
- Metabolism of Drugs by Cytochrome P450 3A IsoformsClinical Pharmacokinetics, 1995
- Coadministration of Fluvoxamine Increases SerumJournal of Clinical Psychopharmacology, 1994
- Clinical Pharmacokinetics of AlprazolamClinical Pharmacokinetics, 1993